[1]
“1H Magnetic Resonance Spectroscopy Assessment of the Effects of Rivastigmine on Patients with moderate Alzheimer Disease”., VITAE, vol. 3, no. 24, Sep. 2005, Accessed: Mar. 30, 2026. [Online]. Available: https://sosvitae.ucv.ve/index.php/vitae/article/view/391